title: An in vitro study of nonadrenergic-noncholinergic activity on the cavernous tissue of mouse.
abstract: The relaxant effects of electrical field stimulation (EFS) and exogenously applied acetylcholine (ACh) or acidified NaNO2 (a-NaNO2) were investigated in the isolated mouse corpus cavernosum precontracted with phenylephrine hydrochloride (PE). Tetrodotoxin (TTX) blocked the relaxant effects of EFS completely, whereas it had no effect on the responses to ACh or a-NaNO2. Guanethidine and indomethacin failed to affect the electrically or ACh-induced relaxations. Atropine completely blocked the effect of ACh; however, it caused a slight reduction in the relaxation evoked by EFS. NG-Nitro-L-arginine (L-NOARG) reduced the effects of EFS and ACh significantly, but it was ineffective on the relaxations induced by a-NaNO2. The inhibitory action of L-NOARG was partly restored by L-arginine, but not by D-arginine. Methylene blue (MB) and hydroxocobalamin (HC) exhibited significant inhibition on the relaxations evoked by EFS, ACh and a-NaNO2. Hydroquinone (HQ) reduced relaxation due to a-NaNO2, but did not affect that of EFS and ACh. Our findings suggest that EFS-induced relaxations of mouse cavernosal tissue are mediated by a transmitter which probably resembles an organic nitrate.
authors.affiliation: Department of Pharmacology, Medical Faculty, Cukurova University, Adana, Turkey.
authors.forename: C
authors.initials: C
authors.lastname: Göçmen
authors.forename: P
authors.initials: P
authors.lastname: Uçar
authors.forename: E
authors.initials: E
authors.lastname: Singirik
authors.forename: A
authors.initials: A
authors.lastname: Dikmen
authors.forename: F
authors.initials: F
authors.lastname: Baysal
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D018663:Adrenergic Agents / Q000494:pharmacology; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000818:Animals; D000931:Antidotes / Q000494:pharmacology; D001120:Arginine / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D004558:Electric Stimulation; D004594:Electrophysiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006397:Hematinics / Q000494:pharmacology; D006873:Hydroquinones / Q000494:pharmacology; D006879:Hydroxocobalamin / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008751:Methylene Blue / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D009153:Mutagens / Q000494:pharmacology; D019335:Nitroarginine / Q000494:pharmacology; D010410:Penile Erection / Q000187:drug effects* / Q000502:physiology*; D010413:Penis / Q000294:innervation* / Q000502:physiology; D010656:Phenylephrine / Q000494:pharmacology; D012977:Sodium Nitrite / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology
chemical_list: D018663:Adrenergic Agents; D000316:Adrenergic alpha-Agonists; D000931:Antidotes; D016861:Cyclooxygenase Inhibitors; D004791:Enzyme Inhibitors; D006397:Hematinics; D006873:Hydroquinones; D009153:Mutagens; D010656:Phenylephrine; D019335:Nitroarginine; D013779:Tetrodotoxin; D001120:Arginine; D012977:Sodium Nitrite; D000109:Acetylcholine; D006879:Hydroxocobalamin; D008751:Methylene Blue; C031927:hydroquinone; D007213:Indomethacin; D006145:Guanethidine